Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · IEX Real-Time Price · USD

9.57

-0.11 (-1.14%)

At close: Jul 19, 2024, 4:00 PM

9.56

-0.01 (-0.10%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Theravance Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Revenue	61.51	57.42	51.35	55.31	71.86	73.41	Upgrade
Revenue Growth (YoY)	26.65%	11.84%	-7.17%	-23.03%	-2.12%	21.61%	Upgrade
Gross Profit	61.51	57.42	51.35	55.31	71.86	73.41	Upgrade
Selling, General & Admin	67.65	70.1	67.07	99.3	108.53	106.08	Upgrade
Research & Development	35.02	40.62	63.39	193.66	260.95	219.25	Upgrade
Other Operating Expenses	1.17	2.74	12.84	20.14	0	0	Upgrade
Operating Expenses	103.84	113.46	143.3	313.1	369.48	325.33	Upgrade
Operating Income	-42.33	-56.04	-91.96	-257.78	-297.63	-251.92	Upgrade
Interest Expense / Income	2.43	2.35	6.37	8.55	8.55	31.86	Upgrade
Other Expense / Income	-7.57	-9.12	-1,149.44	-66.75	-19.64	-42.1	Upgrade
Pretax Income	-37.19	-49.27	1,051	-199.58	-286.54	-241.68	Upgrade
Income Tax	7.58	5.92	178.98	-0.15	-8.52	-5.22	Upgrade
Net Income	-44.77	-55.19	872.13	-199.43	-278.02	-236.46	Upgrade
Shares Outstanding (Basic)	48	55	74	69	62	56	Upgrade
Shares Outstanding (Diluted)	48	55	74	69	62	56	Upgrade
Shares Change	-23.28%	-24.85%	5.95%	11.41%	12.11%	3.04%	Upgrade
EPS (Basic)	-0.88	-1.00	11.85	-2.87	-4.46	-4.25	Upgrade
EPS (Diluted)	-0.88	-1.00	11.85	-2.87	-4.46	-4.25	Upgrade
Free Cash Flow	-17.14	-27.97	-185.7	-211.26	-256.96	-241.37	Upgrade
Free Cash Flow Per Share	-0.35	-0.51	-2.52	-3.04	-4.12	-4.34	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-68.82%	-97.58%	-179.09%	-466.06%	-414.19%	-343.14%	Upgrade
Profit Margin	-72.78%	-96.11%	1698.54%	-360.55%	-386.90%	-322.08%	Upgrade
Free Cash Flow Margin	-27.86%	-48.71%	-361.66%	-381.95%	-357.59%	-328.78%	Upgrade
Effective Tax Rate	-	-	17.03%	-	-	-	Upgrade
EBITDA	-28.73	-40.77	1,065	-182.44	-269.94	-200.15	Upgrade
EBITDA Margin	-46.71%	-70.99%	2074.53%	-329.85%	-375.66%	-272.63%	Upgrade
Depreciation & Amortization	6.03	6.15	7.71	8.59	8.05	9.67	Upgrade
EBIT	-34.76	-46.92	1,057	-191.03	-277.99	-209.82	Upgrade
EBIT Margin	-56.51%	-81.71%	2059.53%	-345.37%	-386.87%	-285.80%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).